Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Imaging beta-amyloid burden in aging and dementia.

Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL.

Neurology. 2007 May 15;68(20):1718-25.

PMID:
17502554
2.

PET imaging of brain amyloid in dementia: a review.

Quigley H, Colloby SJ, O'Brien JT.

Int J Geriatr Psychiatry. 2011 Oct;26(10):991-9. doi: 10.1002/gps.2640. Epub 2010 Dec 28. Review.

PMID:
21905095
3.

The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias.

Villemagne VL, Fodero-Tavoletti MT, Pike KE, Cappai R, Masters CL, Rowe CC.

Mol Neurobiol. 2008 Aug;38(1):1-15. doi: 10.1007/s12035-008-8019-y. Epub 2008 Aug 9. Review.

PMID:
18690556
4.

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Vallabhajosula S.

Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Review.

PMID:
21624562
5.

Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.

Villemagne VL, Rowe CC.

J Alzheimers Dis. 2013;33 Suppl 1:S349-59. Review.

PMID:
22710919
6.

[Amyloid PET in Alzheimer research].

Ishii K.

Brain Nerve. 2010 Jul;62(7):757-67. Review. Japanese.

PMID:
20675880
7.

Amyloid imaging.

Villemagne VL, Rowe CC.

Int Psychogeriatr. 2011 Sep;23 Suppl 2:S41-9. doi: 10.1017/S1041610211000895. Review.

PMID:
21729418
8.

[Molecular imaging of beta-amyloid plaques in the brain].

Ono M.

Brain Nerve. 2007 Mar;59(3):233-40. Review. Japanese.

PMID:
17370649
9.

Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography.

Brooks DJ.

Mov Disord. 2009;24 Suppl 2:S742-7. doi: 10.1002/mds.22581. Review.

PMID:
19877240
10.
11.

[Molecular PET imaging for in vivo detection of amyloid in the human brain].

Okamura N.

Rinsho Shinkeigaku. 2009 Nov;49(11):922-4. Review. Japanese.

PMID:
20030249
12.

Molecular imaging of dementia.

Mori T, Maeda J, Shimada H, Higuchi M, Shinotoh H, Ueno S, Suhara T.

Psychogeriatrics. 2012 Jun;12(2):106-14. doi: 10.1111/j.1479-8301.2012.00409.x. Review.

13.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
14.

Frontotemporal dementia mimicking dementia with Lewy bodies.

Claassen DO, Parisi JE, Giannini C, Boeve BF, Dickson DW, Josephs KA.

Cogn Behav Neurol. 2008 Sep;21(3):157-63. doi: 10.1097/WNN.0b013e3181864a09. Review.

PMID:
18797258
15.

Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

Cohen AD, Rabinovici GD, Mathis CA, Jagust WJ, Klunk WE, Ikonomovic MD.

Adv Pharmacol. 2012;64:27-81. doi: 10.1016/B978-0-12-394816-8.00002-7. Review.

16.

In vivo human amyloid imaging.

Sojkova J, Resnick SM.

Curr Alzheimer Res. 2011 Jun;8(4):366-72. Review.

17.

PET studies in dementia.

Herholz K.

Ann Nucl Med. 2003 Apr;17(2):79-89. Review.

PMID:
12790355
18.

[Introduction to and general remarks on molecular imaging].

Fukuda H, Okamura N.

Brain Nerve. 2007 Mar;59(3):203-7. Review. Japanese.

PMID:
17370645
19.

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo.

Rabinovici GD, Jagust WJ.

Behav Neurol. 2009;21(1):117-28. doi: 10.3233/BEN-2009-0232. Review.

20.

Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.

Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Müller ML, Albin RL, Frey KA.

Mov Disord. 2015 Jun;30(7):928-35. doi: 10.1002/mds.26191. Epub 2015 Apr 16. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk